TCL Archive Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards July 31, 2009
TCL Archive NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved February 26, 1993
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
